KOLINPHARMA® obtains a patent in the United States of America for Dolatrox® - 10/03/2020

A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...

The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

Our From the Floor live blog returns to Philadelphia for CPHI Americas 2026, continuing to showcase the entire pharmaceutical supply chain from north to south across the Americas.

The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...

Anil Kane, PhD, MBA, serves as the Executive Director and Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, a global leader in scientific research and innovation. In this exclusive interview, Kane shares his and Thermo Fisher&#...

Amazon Web Services (AWS) has introduced Amazon Bio Discovery, a new platform designed to harness AI in the field of drug discovery. The initiative aims to address the challenges of lengthy and expensive drug development processes by providing research...

The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.

Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas...